Systematic selection of screening participants by risk score in a Chlamydia screening programme is feasible and effective.

Autor: van den Broek IV, Brouwers EE, Götz HM, van Bergen JE, Op de Coul EL, Fennema JS, Koekenbier RH, Pars LL, van Ravesteijn SM, Hoebe CJ

Publikováno v: Sexually Transmitted Infections; Apr2012, Vol. 88 Issue 3, p205-211, 7p

Acceptability of the internet-based Chlamydia screening implementation in the Netherlands and insights into nonresponse.

Autor: Greenland KE, Op de Coul EL, van Bergen JE, Brouwers EE, Fennema HJ, Götz HM, Hoebe CJ, Koekenbier RH, Pars LL, van Ravesteijn SM, van den Broek IV

Publikováno v: Sexually Transmitted Diseases; Jun2011, Vol. 38 Issue 6, p467-474, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Who cares for syphilis? A cross-sectional study on diagnosis and treatment of syphilis by GPs in Amsterdam, the Netherlands.

Autor: Baas M; General Practice, Amsterdam UMC - Location AMC, Amsterdam, Netherlands michelbaas1994@gmail.com., Beers E; General Practice, Amsterdam UMC - Location AMC, Amsterdam, Netherlands., van Dam AP; Microbiologist, Public Health Service (GGD), Amsterdam, Netherlands.; Microbiologist, Amsterdam UMC - Location AMC, Amsterdam, Netherlands., van Bergen JE; General Practice, Amsterdam UMC - Location AMC, Amsterdam, Netherlands.; SOA AIDS Nederland, Amsterdam, Netherlands.; National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Publikováno v: BJGP open [BJGP Open] 2020 Jun 23; Vol. 4 (2). Date of Electronic Publication: 2020 Jun 23 (Print Publication: 2020).

The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women.

Autor: Hoenderboom BM; Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. Bernice.Hoenderboom@rivm.nl.; Laboratory of Immunogenetics, Department Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands. Bernice.Hoenderboom@rivm.nl., van Oeffelen AA; Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., van Benthem BH; Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., van Bergen JE; Department of General Practice, Division Clinical Methods and Public Health, Academic Medical Center, Amsterdam, the Netherlands.; STI AIDS Netherlands (SOA AIDS Nederland), Amsterdam, The Netherlands., Dukers-Muijrers NH; Department of Sexual Health, Infectious Diseases and Environmental Health, South Limburg Public Health Service (GGD South Limburg), Geleen, The Netherlands.; Department of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Götz HM; Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Department Infectious Disease Control, Municipal Public Health Service Rotterdam-Rijnmond (GGD Rotterdam), Rotterdam, The Netherlands.; Department of Public Health, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands., Hoebe CJ; Department of Sexual Health, Infectious Diseases and Environmental Health, South Limburg Public Health Service (GGD South Limburg), Geleen, The Netherlands.; Department of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Hogewoning AA; STI Outpatient Clinic, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, The Netherlands., van der Klis FR; Laboratory for Infectious Diseases and Perinatal Screening, Centre for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, The Netherlands., van Baarle D; Department Immune Mechanisms, Center for Infectious Disease control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Land JA; Department of Obstetrics and Gynaecology, University Medical Center Groningen, Groningen, The Netherlands., van der Sande MA; Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., van Veen MG; STI Outpatient Clinic, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, The Netherlands., de Vries F; Department of Clinical Pharmacology and Toxicology, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands., Morré SA; Laboratory of Immunogenetics, Department Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands.; Institute for Public Health Genomics (IPHG), Department of Genetics and Cell Biology, Research School GROW (School for Oncology & Developmental Biology), Faculty of Health, Medicine & Life Sciences, University of Maastricht, Maastricht, The Netherlands., van den Broek IV; Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2017 Apr 11; Vol. 17 (1), pp. 264. Date of Electronic Publication: 2017 Apr 11.